Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -19.73%3.08B | 5.14%7.72B | 20.58%3.84B | 20.65%7.35B | 18.73%3.18B | 4.45%6.09B | 17.04%2.68B | 67.47%5.83B | 40.95%2.29B | -11.94%3.48B |
| Operating income | -19.73%3.08B | 5.14%7.72B | 20.58%3.84B | 20.65%7.35B | 18.73%3.18B | 4.45%6.09B | 17.04%2.68B | 67.47%5.83B | 40.95%2.29B | -11.94%3.48B |
| Cost of sales | 19.21%-2.93B | -5.20%-7.28B | -20.45%-3.63B | -21.56%-6.92B | -20.22%-3.01B | -9.18%-5.7B | -27.53%-2.5B | -73.27%-5.22B | -38.81%-1.96B | 12.81%-3.01B |
| Operating expenses | 19.21%-2.93B | -5.20%-7.28B | -20.45%-3.63B | -21.56%-6.92B | -20.22%-3.01B | -9.18%-5.7B | -27.53%-2.5B | -73.27%-5.22B | -38.81%-1.96B | 12.81%-3.01B |
| Gross profit | -28.64%151.3M | 4.16%439.85M | 22.84%212.03M | 7.42%422.26M | -2.37%172.61M | -35.84%393.1M | -45.96%176.8M | 30.29%612.72M | 55.38%327.15M | -5.93%470.29M |
| Employee expense | 5.37%-78.65M | -0.35%-159.09M | -1.76%-83.11M | -2.37%-158.53M | -8.95%-81.67M | 4.22%-154.86M | 3.87%-74.96M | -18.82%-161.69M | -19.06%-77.98M | 7.95%-136.08M |
| Depreciation and amortization | 6.98%-30.37M | 12.42%-62.8M | 12.75%-32.65M | 7.45%-71.7M | 14.09%-37.42M | -2.25%-77.47M | -7.41%-43.56M | -3.22%-75.77M | -16.48%-40.56M | -4.95%-73.4M |
| Impairment and provision | 193.53%910K | -185.47%-1.84M | -145.32%-973K | 198.94%2.15M | 233.52%2.15M | -153.25%-2.17M | -136.98%-1.61M | --4.08M | 7,596.55%4.35M | ---- |
| -Other impairment is provision | 193.53%910K | -185.47%-1.84M | -145.32%-973K | 198.94%2.15M | 233.52%2.15M | -153.25%-2.17M | -136.98%-1.61M | --4.08M | 7,596.55%4.35M | ---- |
| Special items of operating profit | 9.62%-36.2M | -15.76%-93.28M | -32.53%-40.05M | -12.46%-80.58M | -18.80%-30.22M | 17.00%-71.65M | 32.15%-25.44M | -63.17%-86.32M | -48.67%-37.5M | -1.34%-52.91M |
| Operating profit | -87.35%6.99M | 8.14%122.85M | 117.15%55.24M | 30.64%113.6M | -18.55%25.44M | -70.32%86.96M | -82.20%31.24M | 40.94%293.02M | 106.53%175.46M | -9.25%207.9M |
| Financing cost | 4.60%-13.07M | 13.53%-29.74M | 11.56%-13.7M | 5.18%-34.39M | 17.77%-15.49M | 13.45%-36.27M | -0.94%-18.83M | -56.04%-41.9M | -105.81%-18.66M | -19.26%-26.85M |
| Share of profits of associates | 44.08%755K | 107.94%1.2M | -15.89%524K | -9.55%-15.14M | 394.44%623K | ---13.82M | --126K | ---- | ---- | ---- |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -56.11%1M | -59.21%620K | 123.36%2.29M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.08%-12.52M |
| Earning before tax | -112.65%-5.32M | 47.20%94.31M | 297.75%42.07M | 73.77%64.07M | -15.57%10.58M | -85.38%36.87M | -92.04%12.53M | 47.60%252.12M | 133.86%157.43M | -10.82%170.81M |
| Tax | 96.38%-511K | -13.91%-23.66M | -311.95%-14.13M | -15.89%-20.77M | 32.78%-3.43M | 74.47%-17.92M | 87.70%-5.1M | -51.13%-70.2M | -132.63%-41.47M | 12.52%-46.45M |
| After-tax profit from continuing operations | -120.87%-5.83M | 63.16%70.66M | 290.93%27.94M | 128.51%43.3M | -3.74%7.15M | -89.58%18.95M | -93.60%7.43M | 46.28%181.92M | 134.30%115.96M | -10.17%124.36M |
| Earning after tax | -120.87%-5.83M | 63.16%70.66M | 290.93%27.94M | 128.51%43.3M | -3.74%7.15M | -89.58%18.95M | -93.60%7.43M | 46.28%181.92M | 134.30%115.96M | -10.17%124.36M |
| Minority profit | 49.07%1.45M | -24.90%2.87M | 35.85%970K | 57.58%3.82M | -58.42%714K | -54.36%2.42M | -30.03%1.72M | 391.11%5.3M | 280.71%2.45M | -61.32%1.08M |
| Profit attributable to shareholders | -126.99%-7.28M | 71.67%67.79M | 319.24%26.97M | 138.89%39.49M | 12.70%6.43M | -90.64%16.53M | -94.97%5.71M | 43.26%176.62M | 123.22%113.5M | -9.11%123.28M |
| Basic earnings per share | -128.57%-0.02 | 63.64%0.18 | 250.00%0.07 | 175.00%0.11 | 0.00%0.02 | -91.49%0.04 | -93.33%0.02 | 34.29%0.47 | 100.00%0.3 | -14.63%0.35 |
| Diluted earnings per share | -128.57%-0.02 | 63.64%0.18 | 250.00%0.07 | 175.00%0.11 | 0.00%0.02 | -91.49%0.04 | -93.33%0.02 | 34.29%0.47 | 100.00%0.3 | -14.63%0.35 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC accounting firm | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.